ImmuPharma PLC (IMM)

Industry Biotechnology


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

2.11p

Buy

2.33p

arrow-down-0.2121p (-8.89%)

Prices updated at 23 Apr 2024, 14:45 BST
| Prices minimum 15 mins delay
|
Prices in GBX

ImmuPharma PLC is a drug discovery and development company. The company along with its subsidiaries is engaged in the research and development of novel drugs based on peptide therapeutics to treat serious medical conditions including autoimmune diseases.
2.39
triangle-d
arrow-down
-0.17 (-7.34%)
triangle-d
Today open
2.21
triangle-d
arrow-down
-0.04 (-1.68%)
triangle-d
Today, 14:45:45 BST
2.17
triangle-d
2.37p - 2.13p
3.80p - 0.82p
-
9.93m
-
150,000
570,433
5.72
1,368,436.03
2.49
333.40m
GB0033711010
-0.01
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.